Literature DB >> 10353472

Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein.

M Rothenburger1, A Markewitz, T Lenz, H G Kaulbach, K Marohl, W D Kuhlmann, C Weinhold.   

Abstract

OBJECTIVE: Established parameters, e.g. C-reactive protein (CRP), do not differentiate specifically enough between patients developing an infection and those exhibiting an acute phase response following cardiac surgery. The objective of this prospective study was to investigate if procalcitonin (PCT) is more helpful than CRP.
METHODS: During a 1-year period, seven out of 563 patients (1.2%) developed systemic infections (group A) after cardiac operations with cardiopulmonary bypass (CPB), and additional eight patients (1.4%) had local wound infections requiring surgical therapy (group B). Blood samples for PCT and CRP measurements were taken preoperatively, at the onset of infection (d1), as well as on the third day (d3), fifth day (d5), and seventh day (d7) following diagnosis of infection. Forty-four randomly selected patients undergoing cardiac surgery with CPB without clinical signs of infection, additional intensive care unit (ICU) management or additional antibiotic treatment served as control (group C) to assess the PCT and CRP contribution to acute phase response. PCT and CRP levels were measured preoperatively, on the first (d1), third (d3) and fifth day (d5) after operation.
RESULTS: At the onset of infection, PCT levels (median interquartile range 25%-75%) increased significantly in group A as compared to baseline values (10.86 (3.28-15.13) ng/ml vs. 0.12 (0.08-0.21) ng/ml), and decreased during treatment to still significantly elevated values on d5 (0.56 (0.51-0.85) ng/ml). CRP levels were significantly elevated on all days investigated with no trend towards normalisation (d1: 164.5 (137-223) mg/l) vs. 1.95 (1.1-2.8) mg/l preoperatively, d5: 181.1 (134-189.6) mg/l. In group B, no increase in PCT levels, but a significant increase of CRP from d1 (165.9 (96.6-181.6) mg/l) vs. 3.7 (2-4.3) mg/l preoperatively) until d5 98 (92.8-226.2) mg/l was detected. In group C, postoperative PCT levels increased slightly but significantly in the absence of infection on d1 (0.46 (0.26-0.77) ng/ml vs. 0.13 (0.08-0.19) ng/ml preoperatively), and d3 (0.37 (0.2-0.65) ng/ml and reached baseline on d5 (0.24 (0.11-0.51) ng/ml)). CRP levels were significantly elevated as compared to baseline on all postoperative days investigated (baseline: 1.75 (0.6-2.9) mg/l, d1: 97.5 (74.5-120) mg/l), d3: 114 (83.05-168.5) mg/l, d5: 51.4 (27.4-99.8) mg/l)). PCT showed a significant correlation to CRP in group A (r =0.48, p < 0.001), a weak correlation in group C (r=0.27, p=0.002) and no correlation in group B. Intergroup comparison revealed a significant difference for PCT between all groups (A>C>B) and significantly higher CRP levels in group A vs. C and in group B vs. C. Thus, the pattern high PCT/high CRP appears to indicate a systemic infection, while low PCT/high CRP indicates either acute phase response or local wound problems, but no systemic infection. The cost for PCT measurements was 5.6-fold higher as compared to CRP.
CONCLUSION: Due to the significant differences in the degree of increase, PCT appears to be useful in discriminating between acute phase response following cardiac surgery with CPB or local problems and systemic infections, with additional CRP-measurement increasing the specificity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353472     DOI: 10.1515/CCLM.1999.048

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  15 in total

1.  Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction.

Authors:  T Buratti; G Ricevuti; C Pechlaner; M Joannidis; F J Wiedermann; D Gritti; M Herold; C J Wiedermann
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  The role of procalcitonin as a marker of diabetic foot ulcer infection.

Authors:  Mafalda Massara; Giovanni De Caridi; Raffaele Serra; David Barillà; Andrea Cutrupi; Alberto Volpe; Francesco Cutrupi; Antonino Alberti; Pietro Volpe
Journal:  Int Wound J       Date:  2015-10-28       Impact factor: 3.315

3.  C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome.

Authors:  Rafael Sierra; Jordi Rello; María Angeles Bailén; Encarnación Benítez; Antonio Gordillo; Cristobal León; Sebastián Pedraza
Journal:  Intensive Care Med       Date:  2004-09-11       Impact factor: 17.440

4.  Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation.

Authors:  Andrew S Artz; Amittha Wickrema; Shira Dinner; Lucy A Godley; Masha Kocherginsky; Olatoyosi Odenike; Elizabeth S Rich; Wendy Stock; Jodie Ulaszek; Richard A Larson; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2008-11       Impact factor: 5.742

5.  Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.

Authors:  A Jeandrot; J-L Richard; C Combescure; N Jourdan; S Finge; M Rodier; P Corbeau; A Sotto; J-P Lavigne
Journal:  Diabetologia       Date:  2007-10-13       Impact factor: 10.122

6.  Diagnostic value of procalcitonin in acutely hospitalized elderly patients.

Authors:  O Steichen; E Bouvard; G Grateau; S Bailleul; J Capeau; G Lefèvre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-01       Impact factor: 3.267

7.  The pattern of procalcitonin in primary total hip and knee arthroplasty and its implication in periprosthetic infection.

Authors:  Syed Ali; Andrew Christie; Andrew Chapel
Journal:  J Clin Med Res       Date:  2009-05-20

8.  Relevance of Endothelial Cell-Specific Molecule 1 (Endocan) Plasma Levels for Predicting Pulmonary Infection after Cardiac Surgery in Chronic Kidney Disease Patients: The Endolung Pilot Study.

Authors:  Andréa Perrotti; Camille Chenevier-Gobeaux; Fiona Ecarnot; Benoit Barrucand; Philippe Lassalle; Enrica Dorigo; Sidney Chocron
Journal:  Cardiorenal Med       Date:  2017-08-31       Impact factor: 2.041

9.  Kinetic of procalcitonin in patients with cardiogenic shock following acute myocardial infarction: preliminary data.

Authors:  C Picariello; C Lazzeri; M Chiostri; G F Gensini; S Valente
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010

10.  The usefulness of procalcitonin in the diagnosis of appendicitis in children: a pilot study.

Authors:  Abu N G A Khan; Abdel Sawan; Antonios Likourezos; Mark Schnellinger; Estavan Garcia
Journal:  Emerg Med Int       Date:  2012-12-05       Impact factor: 1.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.